Two ceramide derivatives, bathymodiolamides A (1) and B (2), were isolated from the deep-sea hydrothermal vent invertebrate mussel Bathymodiolus thermophilus. The molecular structures of these compounds were determined using a combination of NMR spectroscopy, mass spectrometry, and chemical degradation. Biological activities were assessed in a ApopScreen cell-based screen for apoptosis induction and potential anticancer activity. To our knowledge, this is the first report of secondary metabolites from the marine hydrothermal vent mussel B. thermophilus.The oceans are the Earth's largest ecosystem and hold great, underexplored potential for drug discovery. Within this vast ecosystem, one area remains particularly enigmatic: deepsea hydrothermal vents, which are characterized by high concentrations of reduced sulfur compounds.1 Life is supported by the growth of chemolithoautotrophic bacteria, capable of oxidizing hydrogen sulfide, hydrogen, and other reduced inorganic compounds to provide energy that is used to fuel carbon dioxide fixation into macromolecules. The vent mussel Bathymodiolus thermophilus is characterized by a considerable flexibility in its sources of nutrition. Symbionts within the gills of this organism were found to be thiosulfate-and sulfide-oxidizing chemoautotrophs. In our ongoing effort to discover and develop new marine natural product biomedicinals, we have investigated the ability of the marine hydrothermal vent mussel B. thermophilus to produce novel secondary metabolites.Thirty specimens of B. thermophilus were collected using the deep submergence vehicle DSV Alvin from an active hydrothermal vent along the Mid-Atlantic Ridge, northern region, at the Lucky Strike location with a latitude of 37°17.63′ N, longitude of 32°16.53′ W, and depth of 1733 m.3 Once aboard the research vessel, the mussels were dissected, and samples of adductor muscle, gill, and mantle tissues were frozen at −70 °C for subsequent analyses. One hundred grams wet weight of the tissues from approximately 20 gills was extracted in MeOH. One part of the MeOH-soluble extract was dissolved in DMSO and was tested for apoptosis induction as assessed by the ApopScreen protocol.4 -6 Screening was expected to identify compounds that possess proapoptotic, and potentially anticancer, activity.The extract induced apoptosis and therefore was fractionated, with subsequent purification by analytical reversed-phase HPLC. Using this strategy, two compounds were isolated. The chemical structures of these two compounds (1 and 2) were ascertained by standard spectroscopic techniques, as described below. . Analysis of the multiplicity-edited HSQC spectrum for 1 revealed that these heteroatom-substituted carbons comprise two methylenes (CH 2 -1, δ C 63.7, δ H 3.65; CH 2 -5, δ C 59.9, δ H5a 4.20, δ H5b 4.45) and three methines (CH-2, δ C 53.5, δ H 4.29; CH-3, δ C 62.5, δ H 4.01; CH-4, δ C 66.1, δ H 5.25). The HMBC correlations between H-2 and the carbonyl at δ C 173.2, H-4 and the carbonyl at δ C 173.4, and H-5a and H-5b and the ca...